Intradiscal transplantation of synovial mesenchymal stem cells prevents intervertebral disc degeneration through suppression of matrix metalloproteinase-related genes in nucleus pulposus cells in rabbits by Miyamoto, Takashi et al.
RESEARCH ARTICLE Open Access
Intradiscal transplantation of synovial mesenchymal
stem cells prevents intervertebral disc
degeneration through suppression of matrix
metalloproteinase-related genes in nucleus
pulposus cells in rabbits
Takashi Miyamoto
1, Takeshi Muneta
1,2, Takashi Tabuchi
3, Kenji Matsumoto
4, Hirohisa Saito
4, Kunikazu Tsuji
2,
Ichiro Sekiya
5*
Abstract
Introduction: Synovial mesenchymal stem cells (MSCs) have high proliferative and chondrogenic potentials, and
MSCs transplanted into the articular cartilage defect produce abundant extracellular matrix. Because of similarities
between the articular cartilage and the intervertebral disc cartilage, synovial MSCs are a potential cell source for
disc regeneration. Here, we examined the effect of intradiscal transplantation of synovial MSCs after aspiration of
nucleus pulposus in rabbits.
Methods: The nucleus pulposus tissues of rabbit’s intervertebral discs were aspirated to induce disc degeneration,
and allogenic synovial MSCs were transplanted. At 2, 4, 6, 8, 16, 24 weeks postoperatively, we evaluated with
imaging analyses such as X-ray and magnetic resonance imaging (MRI), and histological analysis. To investigate
interaction between synovial MSCs and nucleus pulposus cells, human synovial MSCs and rat nucleus pulposus
cells were co-cultured, and species specific microarray were performed.
Results: The existence of transplanted cells labeled with DiI or derived from green fluorescent protein (GFP)-
expressing transgenic rabbits was confirmed up until 24 weeks. X-ray analyses demonstrated that intervertebral disc
height in the MSC group remained higher than that in the degeneration group. T2 weighted MR imaging showed
higher signal intensity of nucleus pulposus in the MSC group. Immunohistological analyses revealed higher
expression of type II collagen around nucleus pulposus cells in the MSC group compared with even that of the
normal group. In co-culture of rat nucleus pulposus cells and human synovial MSCs, species specific microarray
revealed that gene profiles of nucleus pulposus were altered markedly with suppression of genes relating matrix
degradative enzymes and inflammatory cytokines.
Conclusions: Synovial MSCs injected into the nucleus pulposus space promoted synthesis of the remaining
nucleus pulposus cells to type II collagen and inhibition of expressions of degradative enzymes and inflammatory
cytokines, resulting in maintaining the structure of the intervertebral disc being maintained.
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Intervertebral discs lie between adjacent vertebrae in the
spine and are composed of three major structures called
nucleus pulposus, annulus fibrosus, and cartilage end
plates [1]. The nucleus pulposus of normal disc includes
sparse chondrocytes surrounded by extracellular matrix
which mainly consist of type II collagen and proteogly-
can. It functions as a shock absorber against mechanical
load due to its highly hydrophilic structure. Interverteb-
ral disc degeneration accompanies aging, and it causes
low back pain [2,3]. To regenerate intervertebral discs,
various approaches applying cytokines [4,5], gene trans-
fection [6], and nucleus pulposus cells [7] have been
attempted in animal models. Some reports have demon-
strated that transplantation of bone marrow mesenchy-
mal stem cells (MSCs) delayed degeneration of the
nucleus pulposus [8-10].
An increasing number of reports have shown that MSCs
can be isolated from other various mesenchymal tissues
other than bone marrow, and that their similarities as
MSCs and the specificities dependent of their MSC source
are emerging [11-13]. Our comparative in vivo study
showed that bone marrow MSCs and synovial MSCs pro-
duced a higher amount of cartilage matrix than adipose
MSCs and muscle MSCs after transplantation into articu-
lar cartilage defect of the knee in rabbits [14]. We also
demonstrated that synovial MSCs expanded faster than
bone marrow MSCs when cultured with 10% human auto-
logous serum [15]. Synovial MSCs and bone marrow
MSCs have a similar chondrogenic potential, but synovial
MSCs are more useful from the standpoint of yield when
cultured with human autologous serum.
Histologically and biochemically, some similarities exist
between the nucleus pulposus and the articular cartilage.
In this study, we investigated whether intradiscal trans-
plantation of synovial MSCs delayed disc degeneration in
a rabbit model. MSCs labeled with DiI or derived from
green fluorescent protein (GFP) expressing transgenic rab-
bit [16] were used for tracking of transplanted cells.
Furthermore, human synovial MSCs and rat nucleus pul-
posus cells were co-cultured in vitro, and their interaction
was clarified by a species specific microarray system.
Finally, we demonstrated the effectiveness and limitations
of this method and advocated a possible mechanism to
prevent intervertebral disc degeneration in a rabbit model.
Materials and methods
Cell isolation and culture
This study was approved by the Animal Experimentation
Committee of Tokyo Medical and Dental University.
Wild type Japanese white rabbits and GFP transgenic
rabbits [16] (Kitayama Labes Co., Ltd., Nagano, Japan)
were anesthetized with an intramuscular injection of
25 mg/kg ketamine hydrochloride and 150 μg/kg mede-
tomidine hydrochloride. Synovium was harvested asepti-
cally from knee joints of the rabbits, and bone marrow
was obtained from their femurs by flushing with Hanks’
balanced salt solution (Invitrogen, Carlsbad, CA, USA).
The harvested synovium was digested in a 3 mg/ml col-
lagenase type V (Sigma-Aldrich Co., St. Louis, MO, USA)
in a-minimal essential medium (aMEM) (Invitrogen) for
three hours at 37°C. The digested tissues were filtered
through a cell strainer (Becton, Dickinson and Company,
Franklin Lakes, NJ, USA) with 70-μmp o r es i z e .T h e
obtained cells were seeded at 5 × 10
4 cells/cm
2 in 145-cm
2
culture dishes (Nalge Nunc International, Rochester, NY,
USA) and cultured with complete medium, aMEM
containing 10% fetal bovine serum (FBS), 100 units/ml
penicillin, 100 μg/ml streptomycin, and 250 ng/ml ampho-
tericin B. The medium was replaced to remove nonadher-
ent cells two days later. After being cultured for seven
days, the cells were harvested with 0.25% trypsin-EDTA
(Invitrogen) and cryopreserved at 1 × 10
6 cells/ml in
aMEM with 5% dimethylsulfoxide (Wako, Osaka, Japan)
and 10% FBS.
The harvested bone marrow was filtered through a cell
strainer with 70-μm pore size and plated in 145-cm
2 cul-
ture dishes with the medium described above and then
incubated at 37°C with 5% humidified CO2. The medium
was replaced the next day. After being cultured for
14 days, the cells were harvested with 0.25% trypsin-
EDTA, replated in 145-cm
2 culture dishes, and cultured
as passage 1. Passage 1 cells were harvested and cryopre-
served after the culture for 14 days.
The frozen cells from synovium and bone marrow were
thawed, plated at 3 × 10
3 cells/cm
2 in 145-cm
2 culture
dishes, and incubated for five days. Harvested cells derived
from wild type rabbits with 0.25% trypsin-EDTA were
r e s u s p e n d e da t1×1 0
6 cells/ml in aMEM, and a DiI
(Molecular Probes, Eugene, OR, USA) fluorescent lipophi-
lic tracer was added at 5 μl/ml in aMEM. After incubation
for 20 minutes at 37°C with 5% humidified CO2, the cells
were centrifuged at 450 g for five minutes and washed
twice with PBS. The obtained cells were used for further
analyses.
Colony-forming unit assay
One thousand cells were plated in 60-cm
2 dishes, cul-
tured in complete medium for 14 days, and stained with
0.5% Crystal Violet in methanol for five minutes.
In vitro differentiation assay
Five hundred cells from rabbit synovium were plated
in 60-cm
2 dishes and cultured in complete medium for
14 days. For adipogenesis, the medium was then switched
to adipogenic medium that consisted of complete
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-7 M dexamethasone,
0.5 mM isobutylmethylxanthine, and 100 μM indometha-
cin. After four days, the adipogenic cultures were stained
with 0.3% Oil Red-O solution. For calcification, the med-
ium was then switched to calcification medium that con-
sisted of complete medium supplemented with 10
-9 M
dexamethasone, 10 mM b-glycerol phosphate, and 50 μg/
ml ascorbate-2-phosphates for an additional six weeks.
T h e s ed i s h e sw e r es t a i n e dw i t h0 . 5 %A l i z a r i nR e ds o l u -
tion. For chondrogenesis, 2 × 10
5 cells were plated in a
15 ml polypropylene tube (BD Falcon, Bedford, MA,
USA) and pelleted by centrifugation at 450 g for 10 min-
utes. The pellets were cultured for 21 days in chondro-
genic medium which contained 1,000 ng/ml bone
morphogenetic protein 7 (Stryker Biotech, Boston, MA,
USA), 10 ng/ml transforming growth factor-b3( R & D
Systems Inc., Minneapolis, MN, USA), and 100 nM dexa-
methasone. For histological analysis, the pellets were
embedded in paraffin, cut into 5-μm sections, and stained
with 1% Toluidine Blue.
In vivo transplantation
Mature female Japanese white rabbits weighing an aver-
age of 3.0 kg were anesthetized as mentioned above. The
anterior surface of the lumbar spine was exposed through
the anterolateral approach, and then L3 to L4, L4 to L5,
and L5 to L6 intervertebral discs were identified. Nucleus
pulposus tissues at L3 to L4 and L5 to L6 discs were aspi-
r a t e du s i n ga2 1 - g a u g en e e d l eo na1 0m ls y r i n g et o
induce disc degeneration [10]. Then, L3 to L4 discs were
untreated and referred to as the “degeneration group.” L5
to L6 discs were injected with 100 μlo f1×1 0
7 allogenic
MSCs/ml in PBS using a 27-gauge needle immediately
after the nucleus pulposus aspiration, and referred to as
the “MSC group.” L4 to L5 discs were approached but
not treated and referred to as the “normal group.” After
the operation, all rabbits were allowed to move in a cage
freely. At 2, 4, 6, 8, 16, 24 weeks postoperatively, the rab-
bits were sacrificed with an overdose of sodium pento-
barbital, and the lumbar spine was harvested.
Imaging analysis
Radiographs were taken immediately after harvest of the
lumbar spine using X-ray equipment (CMB-2; SOFTEX,
Kanagawa, Japan). Intervertebral disc height and verteb-
ral body height were measured, and the disc height
index (DHI) [17] was calculated. Alterations in the DHI
were normalized to the DHI before aspiration of the
nucleus pulposus and are indicated as “%DHI”.
MR imaging at 3.0T (Achieva; Philips Medical Systems,
Andover, MA, USA) was used with an 8-cm diameter sur-
face dual coil. T2-weighted turbo spin-echo images (TE
130 ms, TR 3,200 ms, FOV 140 mm, matrix 320 × 360,
s l i c et h i c k n e s so f3m m )o ft h el u m b a rs p i n ew e r e
obtained at each time point.
Histology and fluorescent microscopy
The intervertebral discs including the adjacent vertebral
bodies were fixed in 4% paraformaldehyde, decalcified
with 20% EDTA, dehydrated in a gradient series of etha-
nol, and embedded in paraffin. Midline sagittal sections
of the intervertebral discs were stained with Hematoxy-
lin and Eosin.
For fluorescent microscopy, the nucleus pulposus was
harvested, fixed in 4% paraformaldehyde, and transferred
to 20% sucrose solution. Specimens were flash-frozen
and cut in a cryostat. Sections were mounted on a slide
and observed under epifluorescent microscopy.
Immunohistochemistry
Paraffin-embedded sections were deparaffinized in
xylene, rehydrated through graded alcohol, and
immersed in PBS. The samples were pretreated with
0.4 mg/ml proteinase K (DAKO, Carpinteria, CA, USA)
in Tris-HCl buffer for 15 minutes at room temperature
for antigen retrieval. Any residual enzymatic activity was
removed by washing with PBS, and nonspecific staining
was blocked by preincubation with PBS containing 10%
normal horse serum for 20 minutes at room tempera-
ture. Mouse monoclonal antibody against human type II
collagen (1:1,000 dilution; Daiichi Fine Chemical,
Toyama, Japan) was placed on each section for one
hour at room temperature. After extensive washing with
PBS, the sections were incubated in the secondary anti-
body of biotinylated horse anti-mouse IgG (Vector
Laboratories, Burlingame, CA, USA) for 30 minutes at
room temperature. Immunostaining was detected with
VECTSTAIN ABC reagent (Vector Laboratories), fol-
lowed by DAB staining. Counter staining was performed
with Mayer-Hematoxylin.
Co-culture experiments and RNA isolation
Human synovium was obtained during anterior cruciate
ligament reconstruction surgery for ligament injury and
digested with 3 mg/ml collagenase type V in aMEM for
three hours at 37°C. The digested tissues were filtered
through a 70-μm pore cell strainer. The obtained cells
were incubated with complete medium as human syno-
vial MSCs. Nucleus pulposus tissues were harvested
from wild type Wister rat, minced, digested for 30 min-
utes at 37°C with 0.01% trypsin-EDTA, and filtered
through a 70-μm pore cell strainer. Nucleated cells were
seeded in 60-cm
2 culture dishes (Nalge Nunc Interna-
tional) with aMEM containing 10% FBS.
For co-culture, both passage 2 human synovial MSCs
and passage 0 rat nucleus pulposus cells were seeded
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2 culture dishes at 3 × 10
3 cells/cm
2,
respectively. For the control, only human synovial MSCs
or only rat nucleus pulposus cells were seeded at 6 ×
10
3 cells/cm
2. After seven days, total RNA was isolated
from cultured cells with the RNeasy Total RNA Mini
Kit (Qiagen, Valencia, CA, USA).
Oligonucleotide microarray
Three μg of total RNA from each sample was first
reverse transcribed to synthesize the first-strand cDNA
using a T7-Oligo(dT) promoter primer by the One-
Cycle cDNA Synthesis Kit (Affymetrix, Santa Clara, CA,
USA). Following RNase H-mediated second-strand
cDNA synthesis, the double-stranded cDNA was puri-
fied and served as a template in the subsequent in vitro
transcription (IVT) reaction. The IVT reaction was car-
ried out in the presence of T7 RNA Polymerase and a
biotinylated nucleotide analog/ribonucleotide mix for
complementary RNA (cRNA) amplification and biotin
labeling using a GeneChip IVT Labeling kit (Affymetrix,
Santa Clara, CA, USA). The biotinylated cRNA targets
were then cleaned up, fragmented, and hybridized to
GeneChip® Rat Genome 230 2.0 probe arrays (Affyme-
trix) and/or GeneChip® Human U-133 plus 2.0 probe
arrays according to the manufacturer’s instructions [18].
Data analysis was performed with GeneSpring soft-
ware version 7.2 (Agilent Technologies, Palo Alto, CA,
USA). To normalize the variations in staining intensity
among chips, the ‘signal’ values for all genes on a given
chip were divided by the median value for expression of
all genes on the chip. To eliminate genes containing
only a background signal, genes were selected only if
the raw values of the ‘signal’ were more than the lower
limit of the confidence interval. Expression of the gene
was judged to be ‘present’ by the GeneChip Operating
Software version 1.4 (Affymetrix). The microarray data
were deposited in the Gene Expression Omnibus [19],
[GEO:GSE24612]. Genes filtered with this quality cri-
teria were subjected to further analysis.
A hierarchical-clustering analysis was performed using a
minimum distance value of 0.001, a separation ratio of 0.5
and the standard definition of the correlation distance.
A dendrogram was obtained from hierarchically clustering
analysis using average linkage and distance metric equal to
one minus the Pearson correlation applied to the microar-
ray data.
Statistical analysis
To assess differences, two-factor ANOVA and Tukey-
Kramer post-hoc tests were used. P-values less than 0.05
were considered statistically significant.
Results
Characteristics of synovial cells as MSCs
A GFP rabbit showed green under its skin, especially in
its muscles and bones under fluorescence (Figure 1a).
Colony forming cells derived from GFP rabbit synovium
Figure 1 Cells from rabbit synovium have characteristics of
MSCs. (a) Right hindlimb of GFP transgenic rabbit. (b) Colony
forming cells derived from GFP transgenic rabbit synovium.
(c) Differentiation potentials.
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These cells differentiated into chondrocytes and adipo-
cytes, and were calcified when cultured in the appropri-
ate differentiation medium (Figure 1c). As MSCs are
defined by adherence to plastic and trilineage differen-
tiation [20], our results indicate that the rabbit syno-
vium-derived cells had characteristics of MSCs.
Existence of transplanted MSCs
DiI labeled synovial MSCs could be detected in the
nucleus pulposus one day after intradiscal injection of
the cells into the normal disc (Figure 2a). After aspira-
tion of nucleus pulposus and injection of labeled syno-
vial MSCs, DiI or GFP positive cells could be observed
at 2, 8, and 24 weeks (Figure 2b).
Imaging analyses for discs
The disc height index was defined as the ratio of disc
height to vertebral body height by lateral radiographs of
the spine (Figure 3a). The disc height index in the
degeneration group decreased gradually and reached
bottom at six weeks. The disc height index in the MSC
group was comparable to that in the normal group up
until 24 weeks. The disc height index in the MSC group
was statistically higher than that in the degeneration
group at two weeks and thereafter (Figure 3b).
We also used injections of bone marrow MSCs instead
of synovial MSCs, and compared the disc height index in
both groups at two weeks. There was no significant dif-
ference of the disc height index between the bone mar-
row MSC group and the synovial MSC group, though the
disc height index in each MSC group was significantly
higher than that in each degeneration group (Figure 3c).
T2-weighted MR images showed that the signal inten-
sity of nucleus pulposus in the degeneration group con-
siderably decreased at two weeks and thereafter.
Contrarily, the signal intensity of nucleus pulposus in
the MSC group remained high comparable with that in
the normal group at two and four weeks. Though the
intensity in the MSC group gradually reduced after six
weeks, it remained higher than that in the degeneration
group up until 24 weeks (Figure 3d).
Histological analysis
According to macroscopic views of the sagittal section of
intervertebral discs at 2 weeks after operation, in the
degeneration group, the nucleus pulposus tissue volume
was much less than that in the normal group (Figure 4a).
Figure 2 Intradiscally injected MSCs remain in the nucleus pulposus at 24 weeks. (a) Disc in normal condition and one day after
intradiscal injection of DiI-labeld syonovial MSCs into the normal disc. Macroscopic views of interbertebral discs and fluorescent microscopic
views of nucleus pulposus are shown. (b) Fluorescent microscopic views for GFP and DiI synovial MSCs. Nucleus pulposus was aspirated in both
groups, and synovial MSCs were intradiscally injected into the MSC group.
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observed.
In low magnified histologies, in the degeneration
group, the nucleus pulposus could hardly be seen at two
weeks and thereafter (Figure 4b). In the MSC group, the
nucleus pulposus looked comparable to a normal one at
two and eight weeks, and it was still visible at 24 weeks.
In high magnified histologies at two weeks, in the
degeneration group, the nucleus pulposus was replaced
with fibrous tissue (Figure 4c). In the MSC group, the
nucleus pulposus consisted of sparse cells surrounded
with matrix and looked similar to that of the normal
group. Interestingly, type II collagen expression in the
MSC group was higher than that in the normal group.
Figure 3 Intradiscally injected MSCs maintain disc height. (a) X-ray image of normal rabbit spine for measurement of disc height index.
(b) Sequential changes of disc height index after transplantation of synovial MSCs. Average percentages of the value are shown with standard
deviations. **P < 0.01 between the degeneration group and the normal group or the MSC group (n = 10 at each time point) by two-factor
ANOVA and Turkey-Kramer post-hoc test. (c) Disc height index at two weeks after transplantation of bone marrow or synovial MSCs. Average
percentages of values with standard deviations. **P < 0.01 between the bone marrow or synovial MSC group and the degeneration group
(n = 6 for each group). (d) Representative T2-weighted MR images of intervertebral discs at 2 to 24 weeks after operation.
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pulposus cells
To investigate interaction between synovial MSCs and
nucleus pulposus cells, human synovial MSCs and rat
nucleus pulposus cells were co-cultured. Typical rat
nucleus pulposus cells attached to the culture dish were
bright and round (Figure 5a). Human synovial MSCs
were spindle-shaped. Though a similar number of rat
nucleus pulposus cells and human synovial MSCs were
co-cultured, only human synovial MSCs appeared to
increase in number at seven days (Figure 5a). Human
microarray showed that the gene profile of human MSCs
cultured alone was similar to that of human MSCs co-
cultured with rat nucleus pulposus cells (Figure 5b).
Figure 4 Intradiscally injected MSCs maintain microstructure of nucleus pulpous. (a) Macroscopic views of the sagittal section of
intervertebral discs at two weeks after operation. (b) Sagittal sections with Hematoxylin-Eosin (HE) staining after operation. (c) Higher
magnification of the framed area with type II collagen immunostaining.
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profile of rat nucleus pulposus cells was widely different
from that of rat nucleus pulposus cells co-cultured with
human MSCs (Figure 5c).
We further analyzed the gene profile of rat microar-
ray. Among 31,099 transcripts, we first picked up 15,779
genes whose values were more than 50 and judged to be
“present.” Then, we selected rat genes whose expression
value were two-fold higher or lower in co-culture than
in mono-culture of rat nucleus pulposus cells. Two
independent microarray analyses demonstrated 172 up-
regulated genes and 7,922 down-regulated genes in
Figure 5 Synovial MSCs affect gene profile of nucleus pulposus cells in co-culture system. (a) Morphology of mono-culture of rat nucleus
pulposus cells and human synovial MSCs at seven days, and co-culture of rat nucleus pulposus cells with human synovial MSCs at one and
seven days. (b) Human gene profile of human synovial MSCs in mono-culture and in co-culture with rat nucleus pulposus cells. (c) Rat gene
profile of rat nucleus pulposus cells in mono-culture and in co-culture with human MSCs. (d) Number of altered rat genes seven days after co-
culture of rat nucleus pulposus cells with human synovial cells by duplicate of microarray analyses.
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(Figure 5d). Approximately 80% of the up-regulated
genes and 90% of the down-regulated genes were over-
lapped as shown by the first and second microarray ana-
lyses, indicating reproducible results.
We next focused on the genes related to extracellular
matrix, and the genes which possibly affect the extracellu-
lar matrix. We found five genes related to collagen, six
genes related to proteoglycan, three genes related to tissue
inhibitor of metalloproteinase (TIMP), seven genes related
to matrix metalloproteinase (MMP), 10 genes related to
interleukin (IL), and six genes related to tumor necrosis
factor (TNF). Among these genes, up- and down- regu-
lated genes two-fold or higher in co-culture are listed in
Table 1. In collagens and proteoglycans, Col2A1, a princi-
pal component of nucleus pulposus, and Chondroitin sul-
fate proteoglycan 2, a member of the hyaluronan-binding
proteoglycan family, were significantly up-regulated,
though Aggrecan 1, another principal component of
nucleus pulposus, was stable and is not listed in Table 1.
Other collagen and proteoglycan related genes were
mostly down-regulated. In the TIMP family, TIMP-3 was
markedly up-regulated, though TIMP-1 and -2 were
down-regulated. All the MMP genes listed on the microar-
ray, especially MMP-2, -3, and -13, were down-regulated
significantly. All inflammatory cytokine-related genes were
also down-regulated. These data indicate that cartilage
catabolic factors were suppressed and anabolic factors
were enhanced, consequently contributing to the preven-
tion of intervertebral disc degeneration.
Discussion
In this study, we demonstrate that intradiscal injection
of synovial MSCs prevented intervertebral disc degen-
eration in rabbits up until 24 weeks. Several reports
have shown differentiation of bone marrow MSCs
toward a nucleus pulposus-like phenotype in vitro
[21-23] and the regenerative effects of bone marrow
MSCs after intradiscal injection [8-10]. To the best of
our knowledge, only one paper has shown in vitro dif-
ferentiation of synovial MSCs into nucleus pulposus in
which synovial MSCs and nucleus pulposus cells were
co-cultured [24]. Ours is the first report demonstrating
the effectiveness of intradiscal transplantation of syno-
vial MSC in rabbit intervertebral disc degeneration
model.
For tracking the transplanted cells, we used DiI and
GFP systems. DiI is a popular dye, highly fluorescent
and photostable when incorporated into lipid membrane
[25,26]. It exhibits low cell toxicity [27], and retains its
fluorescence for a long time in specific situations. How-
ever, there is some criticism in the use of DiI. The emis-
sion of DiI fluorescence decreases every time cells
divide. If DiI leaches out of dying cells, it may be
doubtful whether DiI fluorescence indicates living trans-
planted cells or not. In our case, if the dye had leaked
from the injected MSCs, they would not have emitted
significant fluorescence in the extracellular matrix of
nucleus pulposus, because DiI almost never emits fluor-
escent in aqueous solutions. When leaked DiI transfers
between intact membranes, DiI is usually negligible [28].
To verify the results of tracking cells, we also trans-
planted synovial MSCs derived from a GFP transgenic
rabbit. We could observe GFP-positive and/or DiI
labeled cells at the nucleus pulposus 24 weeks after
transplantation, which demonstrates that transplanted
MSCs survived for some time in the nucleus pulposus.
According to X-ray and histological analyses, the
effect of MSCs could be observed at 24 weeks. Immuno-
histological analyses demonstrated that the amount of
type II collagen in the nucleus pulposus was higher in
t h eM S Cg r o u pt h a ne v e ni nt h en o r m a lg r o u pa tt w o
weeks. Generally, type II collagen functions as a frame
work in cartilage tissues [1,29]. These findings indicate
that transplantation of MSCs induced a higher amount
of type II collagen, which acted as a frame work in the
nucleus pulposus, which resulted in the maintenance of
disc height and histological features.
On the other hand, based on MR imaging, the effect
of MSCs already decreased at six weeks. High signal
intensity of T2 weighted MR imaging reflects the
amount of water in the nucleus pulposus. Possibly,
transplanted MSCs promoted synthesis of proteoglycan,
in which negative charged sulfate held water. In our
study, the ability of MSCs to maintain water was
reduced at six weeks. During the degeneration of inter-
vertebral disc in humans, reduction of water content in
the nucleus pulposus by MR imaging precedes a
decrease of disc height as shown by X-ray [30,31].
In this model, transplantation of MSCs into the inter-
vertebral disc delayed progression of degeneration, but
its effect was not maintained due to MRI imaging. This
result is different from that of previous studies demon-
strating regeneration of articular cartilage. After synovial
MSCs were transplanted into full thickness defect of
articular cartilage, cartilage matrix was filled in the
defect. Then the border between the bone and cartilage
was moved, and finally the thickness of the regenerated
cartilage became similar to that of the adjacent native
cartilage. The regenerated cartilage was maintained at
least for six months [14,32,33]. In our current study,
though extracellular matrix was reproduced by synovial
MSC in the nucleus pulposus, the nucleus pulposus
never thickened more than the normal one. These dif-
ferences were thought to be caused by environmental
differences. Intervertebral disc is a thicker avascular tis-
sue than articular cartilage, and it is not surrounded by
joint fluid or synovium. A severer environment around
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effects of MSCs.
Species specific microarray analyses in our co-culture
experiment revealed that nucleus pulposus cells drama-
tically changed their gene profile by interaction with
synovial MSCs. Contrarily, synovial MSCs did not
change their gene profile in co-culture with nucleus pul-
posus cells. These results demonstrate that synovial
MSCs influenced nucleus pulposus cells, but nucleus
pulposus cells did not affect synovial MSCs.
Co-culture of synovial MSCs increased Col2a1 expres-
sion more than 10-fold in nucleus pulposus cells. An
in vivo study demonstrated that transplantation of synovial
MSCs enhanced type II collagen expression in the nucleus
pulposus immunohistologically. We could not detect type
II collagen expression around labeled MSCs. It is well
known that turnover of cartilage collagen is very slow [34].
These findings indicate that synovial MSCs promoted the
remaining nucleus pulposus to synthesize type II collagen.
Among genes for proteoglycans, chondroitin sulfate
proteoglycan 2 expression increased to about 3-fold in
nucleus pulposus cells with co-culture of synovial
MSCs. Chondroitin sulfate proteoglycan 2, known as
versican, is one of the principal components of nucleus
pulposus, and its expression is higher in nucleus pulpo-
sus than in articular cartilage [35,36]. A possible higher
Table 1 Rat genes up- and down- regulated two-fold or higher in nucleus pulposus cells co-cultured with human
synovial MSCs
Genes Genbank Fold change
Collagens
Col2a1 [Genbank:AF305418] 10.5
Col1a1 [Genbank:Z78279] -2.3
Col5a1 [Genbank:NM_134452] -7.1
Col5a3 [Genbank:NM_021760] -25.3
Proteoglycans
Chondroitin sulfate proteoglycan 2 [Genbank:AF084544] 2.9
Biglycan [Genbank:NM_017087] -7.6
Glypican 1 [Genbank:NM_030828] -13.4
Lumican [Genbank:NM_031050] -16.1
Chondroitin sulfate proteoglycan 4 [Genbank:NM_031022] -18.1
Tissue inhibitor of metalloproteinases
TIMP-3 [Genbank:NM_012886] 27.3
TIMP-1 [Genbank:NM_053819] -2.1
TIMP-2 [Genbank:NM_021989] -4.7
Matrix metalloproteinases
MMP-23 [Genbank:NM_053606] -2.0
MMP-16 [Genbank:NM_080776] -3.0
MMP-11 [Genbank:NM_012980] -3.7
MMP-14 [Genbank:X83537] -6.0
MMP-3 [Genbank:NM_133523] -44.5
MMP-13 [Genbank:M60616] -59.7
MMP-2 [Genbank:U65656] -82.7
Interleukin related
Nuclear factor, IL-3 regulated [Genbank:NM_053727] -2.3
IL-15 [Genbank:AF015718] -3.5
IL-6 signal transducer [Genbank:AI171807] -7.4
IL-11 receptor, alpha chain 1 [Genbank:AF347936] -9.3
Tumor necrosis factor related
TNF receptor superfamily, member 1a (TNFRSF1A) [Genbank:NM_013091] -2.0
TNF-a converting enzyme [Genbank:NM_020306] -2.6
TNF-a induced protein 6 (TSG-6) [Genbank:AF159103] -5.4
Type 1 TNF receptor shedding aminopeptidase regulator [Genbank:NM_030836] -9.0
TNF receptor superfamily, member 6 (TNFRSF6) [Genbank:BE108106] -12.5
A total of 15,779 rat genes consistent with the quality criteria, genes in collagens, proteoglycans, tissue inhibitor of metalloproteinases, matrix metalloproteinases,
interleukin-, and tumor necrosis factor-related genes are listed. IL, interleukin; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of metalloproteinase; TNF,
tumor necrosis factor.
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nucleus pulposus cells induced the holding of water,
resulting in improvements of MR imaging in an in vivo
study.
A number of studies have noted that degradative
enzymes and inflammatory cytokines are highly pro-
duced by nucleus pulposus cells in degenerate interver-
tebral discs [37,38]. According to our microarray
analyses, all MMP genes examined were down-regulated
in nucleus pulposus cells with co-culture of synovial
MSCs. In particular, MMP-2, -3, -13 were highly down-
regulated, and their inhibitor TIMP-3 expression
increased more than 27-fold. It is known that TIMP-3
particularly inhibits aggrecanases [38] and that MMP-
13, known as collagenase-3, has a strong effect on type
II collagen [39]. MMP-2 was also found in degenerated
discs and had a highly significant correlation with age
and histological alterations of intervertebral discs [40].
Suppression of MMPs results in an increase of type II
collagen expression in vivo.
All interleukin related and tumor necrosis factor
related genes listed were down-regulated. All of them
have inflammatory effects. Inhibition of inflammatory
cytokine-related genes could induce the suppression of
MMPs [39,41] which resulted in the preventive effects
of intervertebral disc degeneration.
For clinical application, two things should be consid-
ered. First, species differences will affect the results. We
used rabbits in which nucleus pulposus contained more
notochordal cells than found in adult humans. Noto-
chordal cells have a higher regenerative potential than
other cells in the nucleus pulposus [42,43]. Second, the
choice of intervertebral disc degeneration model should
be considered. In this study, disc degeneration was
induced by aspiration of nucleus pulposus tissues. This
model is caused traumatically and does not mimic
human age-dependent intervertebral disc degeneration.
However, a nucleus pulposus aspiration model is useful
in that nucleus pulposus promptly decreases after
aspiration, and this method could provide rapid and
stable induction of disc degeneration.
The preventive effect of synovial MSCs was similar to
that of bone marrow MSCs in our study. Though it may
be thought that the availability of synovium in human is
lower than that of bone marrow, it really is not. We are
currently conducting a clinical study of transplantation
of autologous synovial MSCs into cartilage defect of the
knee. Synovial tissue can be harvested from the knee
joint under local anesthesia without arthroscopy in clini-
cal practice. Synovial MSCs can be expanded faster and
greater with autologous human serum than bone mar-
r o wM S C s[ 1 5 ] ,w h i c hi sa na d v a n t a g eo fs y n o v i a l
MSCs. Synovial MSCs are a potential cell source for
intervertebral disc regeneration therapy as well as bone
marrow MSCs.
We summarize a possible mechanism of prevention
for intervertebral disc degeneration by intradiscal trans-
plantation of synovial MSCs shown in Figure 6. After
Figure 6 Possible mechanism of prevention for intervertebral disc degeneration by intradiscal transplantation of synovial MSCs. After
aspiration of the nucleus pulposus, intervertebral disc space rapidly decreases. Synovial MSCs injected into the nucleus pulposus space promote
synthesis of type II collagen for the remaining nucleus pulposus cells. Also, synovial MSCs affected the remaining nucleus pulposus cells by
inhibiting expressions of degradative enzymes and inflammatory cytokines, resulting in maintaining the structure of the vertebral disc.
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Page 11 of 13aspiration of the nucleus pulposus, intervertebral disc
space rapidly decreases. Synovial MSCs injected into the
nucleus pulposus space promoted the remaining nucleus
pulposus cells to synthesize type II collagen. Also, syno-
vial MSCs affected the remaining nucleus pulposus cells
by inhibiting their expressions of degradative enzymes
and inflammatory cytokines, resulting in maintaining the
structure of the intervertebral disc.
Conclusions
Intradiscal transplantation of synovial MSCs prevented
intervertebral disc degeneration in vivo. Co-culture assay
in vitro revealed that nucleus pulposus cells dramatically
changed their gene profile by interaction with synovial
MSCs to inhibit expressions of the genes for degradative
enzymes and inflammatory cytokines.
Abbreviations
aMEM: a-minimal essential medium; DHI: disc height index; EDTA:
ethylenediaminetetraacetate; FBS: fetal bovine serum; FOV: field of view; GFP:
green fluorescent protein; IL: interleukin; IVT: in vitro transcription; MMP:
matrix metalloproteinase; MRI: magnetic resonance imaging; MSC:
mesenchymal stem cell; PBS: phosphate-buffered saline; TE: echo time; TIMP:
tissue inhibitor of metalloproteinase; TNF: tumor necrosis factor; TR:
repetition time.
Acknowledgements
We thank Kenichi Shinomiya, MD, PhD, Atsushi Okawa, MD, PhD, and
Tsuyoshi Kato, MD, PhD, for their continuous support; and Miyoko Ojima for
her expert help with histology. This work was supported by a grant from
the Japanese Ministry of Education Global Center of Excellence (GCOE)
Program, the International Research Center for Molecular Science in Tooth
and Bone Diseases, Tokyo Medical and Dental University, Tokyo, Japan. GFP
transgenic rabbits were provided by Kitayama Labes Co., Ltd. Bone
morphogenetic protein 7 was provided by Stryker Biotech.
Author details
1Section of Orthopaedic Surgery, Tokyo Medical and Dental University,
1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
2Global Center of
Excellence Program; International Research Center for Molecular Science in
Tooth and Bone Diseases, Tokyo Medical and Dental University, 1-5-45
Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.
3Medical Satellite Yaesu Clinic,
1-5-9 Yaesu, Chuo-ku, Tokyo 103-0028, Japan.
4Department of Allergy and
Immunology, National Research Institute for Child Health and Development,
2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
5Section of Cartilage
Regeneration, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-
ku, Tokyo 113-8519, Japan.
Authors’ contributions
TMi participated in the design of the study, carried out the animal
experiments, analyzed the results, and drafted the manuscript. TMu
participated in the design of the study and provided the administrative and
financial support. TT carried out the MR imaging. KM and HS carried out the
microarray and participated in the evaluation of the results. KT participated
in the design of the study and provided the financial support. IS participated
in the design of the study, provided the financial support, and completed
the final manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 20 August 2010 Revised: 25 October 2010
Accepted: 5 November 2010 Published: 5 November 2010
References
1. Humzah MD, Soames RW: Human intervertebral disc: structure and
function. Anat Rec 1988, 220:337-356.
2. Reuler J: Low back pain. West J Med 1985, 143:259-265.
3. Deyo R, Weinstein J: Low back pain. N Engl J Med 2001, 344:363-370.
4. Walsh A, Bradford D, Lotz J: In vivo growth factor treatment of
degenerated intervertebral discs. Spine (Phila Pa 1976) 2004, 29:156-163.
5. Masuda K, Imai Y, Okuma M, Muehleman C, Nakagawa K, Akeda K,
Thonar E, Andersson G, An HS: Osteogenic protein-1 injection into a
degenerated disc induces the restoration of disc height and structural
changes in the rabbit anular puncture model. Spine 2006, 31:742-754.
6. Cui M, Wan Y, Anderson D, Shen F, Leo B, Laurencin C, Balian G, Li X:
Mouse growth and differentiation factor-5 protein and DNA therapy
potentiates intervertebral disc cell aggregation and chondrogenic gene
expression. Spine J 2008, 8:287-295.
7. Nomura T, Mochida J, Okuma M, Nishimura K, Sakabe K: Nucleus pulposus
allograft retards intervertebral disc degeneration. Clin Orthop Relat Res
2001, 94-101.
8. Crevensten G, Walsh A, Ananthakrishnan D, Page P, Wahba G, Lotz J,
Berven S: Intervertebral disc cell therapy for regeneration: mesenchymal
stem cell implantation in rat intervertebral discs. Ann Biomed Eng 2004,
32:430-434.
9. Zhang YG, Guo X, Xu P, Kang LL, Li J: Bone mesenchymal stem cells
transplanted into rabbit intervertebral discs can increase proteoglycans.
Clin Orthop Relat Res 2005, 219-226.
10. Sakai D, Mochida J, Iwashina T, Hiyama A, Omi H, Imai M, Nakai T, Ando K,
Hotta T: Regenerative effects of transplanting mesenchymal stem cells
embedded in atelocollagen to the degenerated intervertebral disc.
Biomaterials 2006, 27:335-345.
11. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T: Comparison of human stem
cells derived from various mesenchymal tissues: superiority of synovium
as a cell source. Arthritis Rheum 2005, 52:2521-2529.
12. Mochizuki T, Muneta T, Sakaguchi Y, Nimura A, Yokoyama A, Koga H,
Sekiya I: Higher chondrogenic potential of fibrous synovium- and
adipose synovium-derived cells compared with subcutaneous fat-
derived cells: distinguishing properties of mesenchymal stem cells in
humans. Arthritis Rheum 2006, 54:843-853.
13. Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I:
Comparison of rat mesenchymal stem cells derived from bone marrow,
synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 2007,
327:449-462.
14. Koga H, Muneta T, Nagase T, Nimura A, Ju Y, Mochizuki T, Sekiya I:
Comparison of mesenchymal tissues-derived stem cells for in vivo
chondrogenesis: suitable conditions for cell therapy of cartilage defects
in rabbit. Cell Tissue Res 2008, 333:207-215.
15. Nimura A, Muneta T, Koga H, Mochizuki T, Suzuki K, Makino H, Umezawa A,
Sekiya I: Increased proliferation of human synovial mesenchymal stem
cells with autologous human serum: comparisons with bone marrow
mesenchymal stem cells and with fetal bovine serum. Arthritis Rheum
2008, 58:501-510.
16. Takahashi R, Kuramochi T, Aoyagi K, Hashimoto S, Miyoshi I, Kasai N,
Hakamata Y, Kobayashi E, Ueda M: Establishment and characterization of
CAG/EGFP transgenic rabbit line. Transgenic Res 2007, 16:115-120.
17. Lü D, Shono Y, Oda I, Abumi K, Kaneda K: Effects of chondroitinase ABC
and chymopapain on spinal motion segment biomechanics. An in vivo
biomechanical, radiologic, and histologic canine study. Spine (Phila Pa
1976) 1997, 22:1828-1834, discussion 1834-1825.
18. Kato A, Homma T, Batchelor J, Hashimoto N, Imai S, Wakiguchi H, Saito H,
Matsumoto K: Interferon-alpha/beta receptor-mediated selective
induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC
Immunol 2003, 4:8.
19. Gene Expression Omnibus. [http://www.ncbi.nlm.nih.gov/projects/geo/].
20. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D,
Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining
multipotent mesenchymal stromal cells. The International Society for
Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
21. Risbud MV, Albert TJ, Guttapalli A, Vresilovic EJ, Hillibrand AS, Vaccaro AR,
Shapiro IM: Differentiation of mesenchymal stem cells towards a nucleus
pulposus-like phenotype in vitro: implications for cell-based
transplantation therapy. Spine 2004, 29:2627-2632.
Miyamoto et al. Arthritis Research & Therapy 2010, 12:R206
http://arthritis-research.com/content/12/6/R206
Page 12 of 1322. Steck E, Bertram H, Abel R, Chen B, Winter A, Richter W: Induction of
intervertebral disc-like cells from adult mesenchymal stem cells. Stem
Cells 2005, 23:403-411.
23. Richardson S, Hughes N, Hunt J, Freemont A, Hoyland J: Human
mesenchymal stem cell differentiation to NP-like cells in chitosan-
glycerophosphate hydrogels. Biomaterials 2008, 29:85-93.
24. Chen S, Emery S, Pei M: Coculture of synovium-derived stem cells and
nucleus pulposus cells in serum-free defined medium with
supplementation of transforming growth factor-beta1: a potential
application of tissue-specific stem cells in disc regeneration. Spine (Phila
Pa 1976) 2009, 34:1272-1280.
25. McCauley D, Bronner-Fraser M: Neural crest contributions to the lamprey
head. Development 2003, 130:2317-2327.
26. Mothe A, Tator C: Proliferation, migration, and differentiation of
endogenous ependymal region stem/progenitor cells following minimal
spinal cord injury in the adult rat. Neuroscience 2005, 131:177-187.
27. Crawford J, Braunwald N: Toxicity in vital fluorescence microscopy: effect
of dimethylsulfoxide, rhodamine-123, and DiI-low density lipoprotein on
fibroblast growth in vitro. In Vitro Cell Dev Biol 1991, 27A:633-638.
28. Andrade W, Seabrook T, Johnston M, Hay J: The use of the lipophilic
fluorochrome CM-DiI for tracking the migration of lymphocytes. J
Immunol Methods 1996, 194:181-189.
29. Nerlich A, Boos N, Wiest I, Aebi M: Immunolocalization of major interstitial
collagen types in human lumbar intervertebral discs of various ages.
Virchows Arch 1998, 432:67-76.
30. Berlemann U, Gries N, Moore R: The relationship between height, shape
and histological changes in early degeneration of the lower lumbar
discs. Eur Spine J 1998, 7:212-217.
31. Kim K, Yoon S, Li J, Park J, Hutton W: Disc degeneration in the rabbit: a
biochemical and radiological comparison between four disc injury
models. Spine (Phila Pa 1976) 2005, 30:33-37.
32. Koga H, Muneta T, Ju YJ, Nagase T, Nimura A, Mochizuki T, Ichinose S, von
der Mark K, Sekiya I: Synovial stem cells are regionally specified
according to local microenvironments after implantation for cartilage
regeneration. Stem Cells 2007, 25:689-696.
33. Koga H, Shimaya M, Muneta T, Nimura A, Morito T, Hayashi M, Suzuki S,
Ju Y, Mochizuki T, Sekiya I: Local adherent technique for transplanting
mesenchymal stem cells as a potential treatment of cartilage defect.
Arthritis Res Ther 2008, 10:R84.
34. Verzijl N, DeGroot J, Thorpe S, Bank R, Shaw J, Lyons T, Bijlsma J, Lafeber F,
Baynes J, TeKoppele J: Effect of collagen turnover on the accumulation of
advanced glycation end products. J Biol Chem 2000, 275:39027-39031.
35. Sztrolovics R, Grover J, Cs-Szabo G, Shi S, Zhang Y, Mort J, Roughley P: The
characterization of versican and its message in human articular cartilage
and intervertebral disc. J Orthop Res 2002, 20:257-266.
36. Roughley P: Biology of intervertebral disc aging and degeneration:
involvement of the extracellular matrix. Spine (Phila Pa 1976) 2004,
29:2691-2699.
37. Roberts S, Caterson B, Menage J, Evans E, Jaffray D, Eisenstein S: Matrix
metalloproteinases and aggrecanase: their role in disorders of the
human intervertebral disc. Spine (Phila Pa 1976) 2000, 25:3005-3013.
38. Le Maitre C, Freemont A, Hoyland J: Localization of degradative enzymes
and their inhibitors in the degenerate human intervertebral disc. J
Pathol 2004, 204:47-54.
39. Le Maitre C, Freemont A, Hoyland J: The role of interleukin-1 in the
pathogenesis of human intervertebral disc degeneration. Arthritis Res
Ther 2005, 7:R732-745.
40. Weiler C, Nerlich A, Zipperer J, Bachmeier B, Boos N: 2002 SSE Award
Competition in Basic Science: expression of major matrix
metalloproteinases is associated with intervertebral disc degradation
and resorption. Eur Spine J 2002, 11:308-320.
41. Séguin C, Pilliar R, Madri J, Kandel R: TNF-alpha induces MMP2 gelatinase
activity and MT1-MMP expression in an in vitro model of nucleus
pulposus tissue degeneration. Spine (Phila Pa 1976) 2008, 33:356-365.
42. Hunter C, Matyas J, Duncan N: The notochordal cell in the nucleus
pulposus: a review in the context of tissue engineering. Tissue Eng 2003,
9:667-677.
43. Miyazaki T, Kobayashi S, Takeno K, Meir A, Urban J, Baba H: A phenotypic
comparison of proteoglycan production of intervertebral disc cells
isolated from rats, rabbits, and bovine tails; which animal model is most
suitable to study tissue engineering and biological repair of human disc
disorders? Tissue Eng Part A 2009, 15:3835-3846.
doi:10.1186/ar3182
Cite this article as: Miyamoto et al.: Intradiscal transplantation of synovial
mesenchymal stem cells prevents intervertebral disc degeneration
through suppression of matrix metalloproteinase-related genes in nucleus
pulposus cells in rabbits. Arthritis Research & Therapy 2010 12:R206.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Miyamoto et al. Arthritis Research & Therapy 2010, 12:R206
http://arthritis-research.com/content/12/6/R206
Page 13 of 13